@article{8a8e8caea39a4db6b33bf48186a3044f,
title = "Concerns about the taxonomy, definition and coding of fibromyalgia syndrome in ICD-11: the potential for negative consequences for patient care and research",
author = "W. H{\"a}user and Clauw, \{D. J.\} and F. Wolfe and P. Sarzi-Puttini and Ablin, \{J. N.\} and C. Usui and Littlejohn, \{G. O.\} and B. Morlion and E. Kosek and Fors, \{E. A.\} and \{{\O}ien Forseth\}, \{K. M.\} and Fitzcharles, \{M. A.\}",
note = "Funding Information: W. H{\"a}user was the head of the steering committee of the German guidelines on FMS and member of the European League Against Rheumatism task force on revised recommendations for the management of FMS. He is a member of the medical board of the European Network of Fibromyalgia Associations and of the German Fibromyalgia Asso ciation*. D. Clauw reports grants from Aptinyx, Daiichi Sankyo, Eli Lilly, Intec Phar ma, and Pfizer; personal fees from Apt-inyx, Nix Patterson, Pfizer, Samumed, Theravance, Tonix, Williams \& Connolly, and Zynerba; has consulted for Aptinyx, Eli Lilly, Pfizer, Samumed, and Tonix and has received research funding from Aptinyx. J.N. Ablin has given voluntary consult ing and educational activities to the Israeli association of fibromyalgia and chronic fatigue patients*. He was the head of the steering committee of the Israeli guidelines on FMS. P. Sarzi-Puttini is a member of the medical board of the Italian Fibromyal-gia Syndrome Association* and member of the steering committee of the Italian Society for Rheumatology clinical practice guidelines for the diagnosis and management of fibromyalgia. C. Usui is vice president of Japan College of Fibromyalgia Investigation and the head of the steering committee of the Japanese guidelines on FM. B. Morlion has received honoraria for speaker{\textquoteright}s activities from Gr{\"u}nenthal, Lilly, Mundipharma, Pfizer, Krka, Ache, Sandoz, Shionogi and for consultancy activities from Gr{\"u}nenthal, Mundipharma, TEVA, GSK, Kyowa-Kirin, Pfizer, Lilly, Boston Scientific, Reckitt\&Benckiser and Shionogi. E. Kosek has received a research grant from FOREUM. E. Fors is a member of the medical ad visory board of the Norwegian Fibro- myalgia Association*. K.M. {\O}ien Forseth is a member of the medical board of the European Net work of fibromyalgia Associations*. M.-A. Fitzcharles was the head of the steering committee of the Canadian guideline on FMS. *The commentary has not been man dated by the FMS self-help organisa tions.",
year = "2022",
month = jun,
doi = "10.55563/clinexprheumatol/3bt9qx",
language = "English",
volume = "40",
pages = "1073--1075",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology",
number = "6",
}